2018.02
The role of circulating cell-free DNA in the management of cancer in China
![1651718025384879.jpg 1.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651718025384879.jpg)
![1651718036247930.jpg 2.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651718036247930.jpg)
![1651718043311258.jpg 3.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651718043311258.jpg)
![1651718050490089.jpg 4.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651718050490089.jpg)
![1651718055526298.jpg 5.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651718055526298.jpg)
![1651718061652126.jpg 6.jpg](http://english.genecast.com.cn/uploads/img/ueditor/image/20220505/1651718061652126.jpg)
Pictures are from Science.Precision medicine and cancer immunology in China.
Quality Control of Next-generation Sequencing-based In vitro Diagnostic Test for Onco-relevant Mutations Using Multiplex Reference Materials in Plasma
Diagnostic Value of Circulating Cell-Free DNA Levels for Hepatocellular Carcinoma